SCHEMBL20179681

SCHEMBL20179681

O=CCCC(CCC=O)CCC=O

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.44
ALDH1A1 P00352 1/20 0.39
TSHR P16473 2/20 0.35
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6859069 0.85 ALDH1A1 (0.50) HIF1AALDH1A1TSHRTDP1
SCHEMBL19455882 0.85 ALDH1A1 (0.50) HIF1AALDH1A1TSHRTDP1
SCHEMBL6544195 0.83 HIF1A (0.37) HIF1AALDH1A1TSHR
SCHEMBL10897741 0.83 ALDH1A1 (0.48) HIF1AALDH1A1TSHRTDP1
SCHEMBL2452696 0.81
SCHEMBL229943 0.81
SCHEMBL9770261 0.81 TSHR (0.55) HIF1AALDH1A1TSHRTDP1
SCHEMBL28511546 0.79 TSHR (0.52) HIF1AALDH1A1TSHRTDP1
SCHEMBL1682010 0.78 ALDH1A1 (0.43) HIF1AALDH1A1TSHRTDP1
SCHEMBL8352114 0.77 TSHR (0.50) HIF1AALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11254786-B2 Multifunctional degradable nanoparticles with control over size and functionalities VANDERBILT UNIVERSITY (US) 2022-02-22 US disclosed
US-10442890-B2 Multifunctional degradable nanoparticles with control over size and functionalities VANDERBILT UNIVERSITY (US) 2019-10-15 US disclosed
US-20180142061-A1 Multifunctional Degradable Nanoparticles with Control over Size and Functionalities UNIV VANDERBILT (US) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11254786-B2 Multifunctional degradable nanoparticles with control over size and functionalities DSTN, PARN, CTSA HIF1A 491/4885ALDH1A1 1776/4885TSHR 2807/4885
US-10442890-B2 Multifunctional degradable nanoparticles with control over size and functionalities DSTN, PARN, CTSA HIF1A 491/4885ALDH1A1 1776/4885TSHR 2807/4885
US-20180142061-A1 Multifunctional Degradable Nanoparticles with Control over Size and Functionalities DSTN, PARN, CTSA HIF1A 491/4885ALDH1A1 1776/4885TSHR 2807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.